Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Cancer Res. 2014 Mar 19;74(10):2785–2795. doi: 10.1158/0008-5472.CAN-13-3176

Figure 5. CLPTM1L and non-muscle Myosin II localize to centrosomes.

Figure 5

Co-localization of CLPTM1L (A) and non-muscle myosin II (B) with the centrosome marker γ-tubulin by in situ Proximity Ligation Assay (DPLA). (C) Co-localization of WT CLPTM1L and γ-tubulin by immunofluorescence analysis. PANC-1 cells stably expressing N-FLAG CLPTM1L were treated for 2 days with 50 μM cisplatin in all panels. The yellow signal in the lower right panel shows co-localization of CLPTM1L and γ-tubulin.